Literature DB >> 4611523

Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease.

W G Johnson, R J Desnick, D M Long, H L Sharp, W Krivit, B Brady, R O Brady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4611523

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN： 0547-6844


× No keyword cloud information.
  12 in total

1.  Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Authors:  R J Desnick; K J Dean; G Grabowski; D F Bishop; C C Sweeley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

Review 2.  Emptying the stores: lysosomal diseases and therapeutic strategies.

Authors:  Frances M Platt
Journal:  Nat Rev Drug Discov       Date:  2017-11-17       Impact factor: 84.694

3.  Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain.

Authors:  Diane Golebiowski; Imramsjah M J van der Bom; Churl-Su Kwon; Andrew D Miller; Keiko Petrosky; Allison M Bradbury; Stacy Maitland; Anna Luisa Kühn; Nina Bishop; Elizabeth Curran; Nilsa Silva; Dwijit GuhaSarkar; Susan V Westmoreland; Douglas R Martin; Matthew J Gounis; Wael F Asaad; Miguel Sena-Esteves
Journal:  Hum Gene Ther       Date:  2017-01-26       Impact factor: 5.695

4.  Sphingolipidoses.

Authors:  K Sandhoff
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

5.  Immunological aspects of urate oxidase therapy in hyperuricaemia.

Authors:  D A Fitzpatrick; O FitzGerald; K F McGeeney
Journal:  Ir J Med Sci       Date:  1977-06       Impact factor: 1.568

6.  Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats.

Authors:  E A Neuwelt; W G Johnson; N K Blank; M A Pagel; C Maslen-McClure; M J McClure; P M Wu
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood--brain barrier.

Authors:  E A Neuwelt; J A Barranger; R O Brady; M Pagel; F S Furbish; J M Quirk; G E Mook; E Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

Review 8.  Enzyme replacement therapy: conception, chaos and culmination.

Authors:  Roscoe O Brady
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

Review 9.  New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy.

Authors:  Michael Beck
Journal:  Hum Genet       Date:  2006-11-07       Impact factor: 5.881

Review 10.  Genetics and Therapies for GM2 Gangliosidosis.

Authors:  Maria Begona Cachon-Gonzalez; Eva Zaccariotto; Timothy Martin Cox
Journal:  Curr Gene Ther       Date:  2018       Impact factor: 4.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.